These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 3697784)
1. Apomorphine and haloperidol effects on striatal 3H-dopamine release in anesthetized, awake restrained and freely moving rats. Spampinato U; Girault JA; Danguir J; Savaki HE; Glowinski J; Besson MJ Brain Res Bull; 1986 Feb; 16(2):161-6. PubMed ID: 3697784 [TBL] [Abstract][Full Text] [Related]
2. Release of newly synthesized 3H-dopamine in the striatum: an adaptation of the push-pull cannula method to awake restrained and anesthetized rats. Savaki HE; Girault JA; Spampinato U; Truong NA; Glowinski J; Besson MJ Brain Res Bull; 1986 Feb; 16(2):149-54. PubMed ID: 3697783 [TBL] [Abstract][Full Text] [Related]
3. Brain tyrosine depletion attenuates haloperidol-induced striatal dopamine release in vivo and augments haloperidol-induced catalepsy in the rat. Jaskiw GE; Bongiovanni R Psychopharmacology (Berl); 2004 Feb; 172(1):100-7. PubMed ID: 14586541 [TBL] [Abstract][Full Text] [Related]
4. Apomorphine does not reverse reduced basal dopamine release in rat striatum and nucleus accumbens after chronic haloperidol treatment. Ichikawa J; Meltzer HY Brain Res; 1990 Jan; 507(1):138-42. PubMed ID: 2302571 [TBL] [Abstract][Full Text] [Related]
5. [The effect of halothane anesthesia on dopamine release induced by apomorphine or haloperidol--an in vivo microdialysis study in rats striatum]. Adachi Y; Wada H; Higuchi H; Watanabe K; Satoh T Masui; 2001 Oct; 50(10):1089-95. PubMed ID: 11712340 [TBL] [Abstract][Full Text] [Related]
6. Alterations in dopamine release from striatal slices of rats after chronic treatment with haloperidol. Yamada S; Yokoo H; Harajiri S; Nishi S Eur J Pharmacol; 1991 Jan; 192(1):141-5. PubMed ID: 2040357 [TBL] [Abstract][Full Text] [Related]
7. Differential effects of repeated treatment with haloperidol and clozapine on dopamine release and metabolism in the striatum and the nucleus accumbens. Ichikawa J; Meltzer HY J Pharmacol Exp Ther; 1991 Jan; 256(1):348-57. PubMed ID: 1703232 [TBL] [Abstract][Full Text] [Related]
8. 8-OH-DPAT, a 5-HT1A agonist and ritanserin, a 5-HT2A/C antagonist, reverse haloperidol-induced catalepsy in rats independently of striatal dopamine release. Lucas G; Bonhomme N; De Deurwaerdère P; Le Moal M; Spampinato U Psychopharmacology (Berl); 1997 May; 131(1):57-63. PubMed ID: 9181636 [TBL] [Abstract][Full Text] [Related]
9. Cytidine(5')diphosphocholine enhances the ability of haloperidol to increase dopamine metabolites in the striatum of the rat and to diminish stereotyped behavior induced by apomorphine. Agut J; Coviella IL; Wurtman RJ Neuropharmacology; 1984 Dec; 23(12A):1403-6. PubMed ID: 6543245 [TBL] [Abstract][Full Text] [Related]
10. Effects of buspirone on dopamine dependent behaviours in rats. Dhavalshankh AG; Jadhav SA; Gaikwad RV; Gaonkar RK; Thorat VM; Balsara JJ Indian J Physiol Pharmacol; 2007; 51(4):375-86. PubMed ID: 18476392 [TBL] [Abstract][Full Text] [Related]
11. Tolerance phenomena with neuroleptics catalepsy, apomorphine stereotypies and striatal dopamine metabolism in the rat after single and repeated administration of loxapine and haloperidol. Asper H; Baggiolini M; Burki HR; Lauener H; Ruch W; Stille G Eur J Pharmacol; 1973 Jun; 22(3):287-94. PubMed ID: 4738903 [No Abstract] [Full Text] [Related]
12. Effects of cholecystokinin octapeptide on striatal dopamine metabolism and on apomorphine-induced stereotyped cage-climbing in mice. Kovács GL; Szabó G; Penke B; Telegdy G Eur J Pharmacol; 1981 Jan; 69(3):313-9. PubMed ID: 6260512 [TBL] [Abstract][Full Text] [Related]
13. Effects of neuroleptics on release of 3H-dopamine from slices of rat corpus striatum. Dismukes K; Mulder AH Naunyn Schmiedebergs Arch Pharmacol; 1977 Mar; 297(1):23-9. PubMed ID: 16224 [TBL] [Abstract][Full Text] [Related]
14. Apomorphine enantiomers' effects on dopamine metabolism: receptor and non-receptor related actions. Saller CF; Salama AI Eur J Pharmacol; 1986 Feb; 121(2):181-8. PubMed ID: 3699091 [TBL] [Abstract][Full Text] [Related]
15. Neuroleptic-like effects of the l-isomer of fenfluramine on striatal dopamine release in freely moving rats. Bettini E; Ceci A; Spinelli R; Samanin R Biochem Pharmacol; 1987 Jul; 36(14):2387-91. PubMed ID: 2886127 [TBL] [Abstract][Full Text] [Related]
16. Changes in sensitivity of release modulating dopamine autoreceptors after chronic treatment with haloperidol. Nowak JZ; Arbilla S; Galzin AM; Langer SZ J Pharmacol Exp Ther; 1983 Aug; 226(2):558-64. PubMed ID: 6875865 [TBL] [Abstract][Full Text] [Related]
17. The effect of apomorphine and bradykinin on uptake and release of dopamine in vitro by striatal synaptosomes of the rat. Borawska M; Wiśniewski K Pol J Pharmacol Pharm; 1982; 34(1-3):79-84. PubMed ID: 7167424 [TBL] [Abstract][Full Text] [Related]
18. Delayed effects of neonatal hippocampal damage on haloperidol-induced catalepsy and apomorphine-induced stereotypic behaviors in the rat. Lipska BK; Weinberger DR Brain Res Dev Brain Res; 1993 Oct; 75(2):213-22. PubMed ID: 7903225 [TBL] [Abstract][Full Text] [Related]
19. Electrophysiological and pharmacological characteristics of nigral dopaminergic neurons in the conscious, head-restrained rat. Fà M; Mereu G; Ghiglieri V; Meloni A; Salis P; Gessa GL Synapse; 2003 Apr; 48(1):1-9. PubMed ID: 12557266 [TBL] [Abstract][Full Text] [Related]
20. SCH 23390 may alter dopamine-mediated motor behaviour via striatal D-1 receptors. Boyce S; Kelly E; Davis A; Fleminger S; Jenner P; Marsden CD Biochem Pharmacol; 1985 May; 34(10):1665-9. PubMed ID: 2988552 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]